• New data show rising burden of most cardiovascular risk factors among young adults aged 20 to 44 in the U.S.
• Findings are “extremely concerning” as expert notes “we’re witnessing a smoldering public health crisis”
• HeartBeam has developed the first and only 3D-vector electrocardiogram for heart attack detection anytime, anywhere

A recent study shows that risk factors for cardiovascular (“CV”) disease are rising among young adults (https://ibn.fm/jvjFN). Studies like this that provide critical information regarding CV disease highlight the ongoing urgency of HeartBeam’s efforts. HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector electrocardiogram for heart attack detection anytime, anywhere.

“New data show a high and rising burden of most cardiovascular risk factors among young adults aged 20 to 44 years in the United States,” states a Medscape article, reporting on study findings presented at the March 5 annual meeting of the American College of Cardiology (“ACC”). “In this age group, over the past 10 years, there has been an increase in the prevalence of diabetes and obesity, no improvement in the prevalence of hypertension, and a decrease in the prevalence of hyperlipidemia.

“Yet medical treatment rates for CV risk factors are ‘surprisingly’ low among young adults,” study investigator Rishi Wadhera, MD, with Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, told theheart.org / Medscape Cardiology.

In the article, Wadhera noted that the findings are “extremely concerning.” He stated that “we’re witnessing a smoldering public health crisis. The onset of these risk factors earlier in life is associated with a higher lifetime risk of heart disease and potentially life threatening.”

The cross-sectional study comprised 12,294 U.S. participants aged 20 to 44 who participated in National Health and Nutrition Examination Survey (“NHANES”) cycles for 2009–2010 and 2017–March 2020. The mean age of group participants was 32, and 51% of participants were women.

The article reported that, “overall, the prevalence of hypertension was 9.3% in 2009–2010 and increased to 11.5% in 2017–2020. The prevalence of diabetes rose from 3.0% to 4.1%, and the prevalence of obesity rose from 32.7% to 40.9%. The prevalence of hyperlipidemia decreased from 40.5% to 36.1%.

“Equally concerning, said Wadhera, only about 55% of young adults with hypertension were receiving antihypertensive medication, and just 1 in 2 young adults with diabetes were receiving treatment,” the article continued. “Wadhera said, ‘We need to double down on efforts to screen for and treat cardiovascular risk factors like high blood pressure and diabetes in young adults. We need to intensify clinical and public health interventions focused on primordial and primary prevention in young adults now so that we can avoid a tsunami of cardiovascular disease in the long term. It’s critically important that young adults speak with their healthcare provider about whether ― and when ― they should undergo screening for high blood pressure, diabetes, and high cholesterol.’”

Working closely with healthcare providers is a key focus of HeartBeam’s technology. By applying a suite of proprietary algorithms to simplify vector electrocardiography (“VECG”), the HeartBeam platform enables patients and their clinicians to determine quickly and easily if symptoms are due to a heart attack so care can be expedited if required.

HeartBeam has two patented products in development. HeartBeam AIMI(TM) is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack more accurately. HeartBeam AIMIGo(TM) is the first and only credit-card-sized, 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart-attack detection. HeartBeam AIMI and AIMIGo have not yet been cleared by the U.S. Food and Drug Administration (“FDA”) for marketing in the United States or other geographies.

For more information, visit the company’s website at www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

• Rare earth element (“REE”) processing solutions developer Ucore Rare Metals Inc. is preparing to demonstrate the prowess of its proprietary RapidSX (TM) technological advantage as an improvement over standard REE ore separation processes
• REE production has become a matter of strategic importance to American industries and tech-based military applications, as China has built global control of vital REE markets and demonstrated a willingness to stop REE exports during international disputes
• Ucore is preparing to launch construction of a Strategic Metals Complex (“SMC”) in Louisiana later this year after demonstrating RapidSX (TM) potential at its Canadian base
• Ucore’s SMC will be the first in a series of processing facilities drawing on “allied” Western ore sources for rapid throughput of REEs to market in North America
• The company also owns an REE mine prospect in Alaska that it intends to start up once financing is secured

Tensions in an evolving tech war between the United States and China grew this month as the Netherlands announced it would agree to limit the export of “advanced” semiconductor manufacturing equipment (https://ibn.fm/aOAju) as a result of an agreement it quietly ratified with Japan and the United States in January (https://ibn.fm/W4aJe).

The export limits, which tacitly are aimed at restraining China’s world dominance in mining resources for next-generation technology used in everything from cell phones and electric vehicles to military assets, demonstrate the cooperative efforts Western governments and industries are undertaking to prevent becoming dependent on the Asian nation, whose population and economy (when measured by purchasing power parity) are the largest on earth (https://ibn.fm/P9vfJ).

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a Canadian company developing specialized rare earth element (“REE”) separation and processing solutions, is playing a role in reasserting North America’s independence in tech resource mining. The company is preparing to demonstrate its proprietary RapidSX (TM) process for the low-cost separation and purification of REEs through an accelerated form of solvent extraction at a Demonstration Plant in Ontario.

Commissioning of the Demonstration Plant is currently under way, according to a Jan. 26 Ucore statement (https://ibn.fm/eXtNB).

Ucore then intends to demonstrate its position as an REE thought leader by building a “Strategic Metals Complex” (“SMC”) processing facility in Louisiana later this year, followed by additional SMCs at sites in Alaska and Canada. The SMC processing facilities network, using Ucore’s RapidSX (TM) technology to improve on the standard SX solvent extraction process used by 100 percent of all REE producers worldwide, has the potential to help the West retain control of its supply chain for the mineral resources.

That need became particularly apparent when China leveraged its control over rare earth production to block Japan’s access to REEs in 2010 following a dispute over a dangerous fishing trawler’s detention in waters claimed by both nations (https://ibn.fm/l1n9W). Tensions between the United States and China during the Trump administration and a new Chinese threat to limit REE sourcing increased the emphasis on turning to in-country production for U.S. technologies (https://ibn.fm/sHyz6).

The Pentagon has subsequently provided millions of dollars in funding to Las Vegas-based MP Materials, which owns the Mountain Pass mine in California. Mountain Pass is currently the only operating rare earth mine and processing facility in the United States. A few other companies have been attempting to join in to help jump start large-scale U.S. production of rare earths, but the effort is time- and cost-intensive since virtually all formerly operating rare earth mines shut down on a global scale after China entered the market in the 1980s and began flooding it with low-cost REEs, independent research group Adamas Intelligence founder Ryan Castilloux stated in a Politico report on the matter (https://ibn.fm/qJHMH).

“(China) leveraged that monopoly on rare earths supply to subsequently dominate all of the value-adding steps, from mine through to metal through to magnet,” Castilloux stated.

The Politico report notes going from raw ore to magnet is an expensive, multi-step process that currently takes place across multiple continents — Mountain Pass’s ore is currently processed in China, for example. Ucore aims to employ its RapidSX (TM) processing technology and SMCs in quickly moving mined rare earths to market domestically, using “allied” rare earth feedstock derived from mines around the world, according to an Alaska Journal of Commerce report (https://ibn.fm/8ss33).

Ucore owns a rare earth mine prospect on Alaska’s Prince of Wales Island that it acquired in 2007, which it aims to ultimately develop as an additional strategic REE source for its supply chain. The mine on the Bokan Mountain-Dotson Ridge holds more than 4.7 million metric tons of indicated rare earth ore, according to a 2015 resource assessment, the Journal of Commerce report states. That translates to about 63.5 million pounds of collective rare earth metals.

Alaska’s Legislature approved up to $145 million in bonds to help finance the Bokan Mountain mine in 2014. Ucore officials state if they can obtain funding for the remainder of the mine startup, estimated at $220 million in 2013, Bokan can be “near shovel-ready” within 30 months, according to the Journal report.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• Progressive Care reported a 4% year-over-year revenue increase to approximately $10.1 million for the quarter ended September 30, 2022
• The company’s prescription revenue increased 16% year-over-year to almost $9.4 million during that same period
• In 2022, Progressive Care received nearly $6 million from a strategic investment transaction with NextPlat Corporation
• The company launched its ClearMetrX platform for 340B third-party administration in 2022
• Progressive Care will partner with MedAvail in2023 to provide prescription dispensing kiosks

Progressive Care (OTCQB: RXMD) is a health services organization based in Florida that offers personalized healthcare services and technology that supports the managed healthcare industry. Through its subsidiaries, Progressive Care provides Third-Party Administration (“TPA”), data management and analytics, COVID-19 diagnostics and vaccinations, 340B contracted pharmacy services, compounded medications, tele-pharmacy services, dispensing of anti-retroviral medications, medication therapy management (“MTM”), long-term care facility-targeted prescription medications, and health practice risk management. The company collaborates with various healthcare organizations such as managed care organizations (“MCOs”), management services organizations (“MSOs”), accountable care organizations (“ACOs”), primary care providers, Medicare Advantage plans, Medicaid, commercial payors, pharmaceutical manufacturers, and distributors to enhance patient and provider engagement while improving the lives of patients with chronic diseases. Progressive Care offers a wide range of innovative solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. Progressive Care currently operates four pharmacies in Florida, which generate the majority of its revenue. Pharmacy revenue is derived from dispensing medications, third-party administrative services to 340B-covered entities, and MTM services. The company also provides customized management, patient health risk reviews, and free same- and next-day delivery. Its focus is on complex chronic diseases that require multiyear or lifelong therapy, driving recurring revenue and sustainable growth. Progressive Care’s pharmacy revenue growth stems from its expanding breadth of services, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers resulting from its emphasis on higher patient engagement, free delivery to the patient, and clinical expertise. With licenses in 14 states, Progressive Care is poised for national expansion. The company anticipates revenue growth by signing new contract pharmacy service and data management contracts with 340B-covered entities, expanding data management and analytics services to healthcare organizations, and potential acquisitions. Subsidiaries Progressive Care’s wholly-owned subsidiaries provide services to client organizations and patients. PharmcoRx Pharmacy PharmcoRx, a full-service pharmacy, provides a complete healthcare ecosystem with services such as medication therapy management, rapid COVID-19 testing and vaccines, contactless medication delivery, Smart-Pack Unit Dosing packaging, custom compound medications, specialty medications, hospital transition pharmacy services, medication adherence monitoring, medication adherence risk management, and drug cost containment. PharmcoRx Pharmacy is a contracted pharmacy services provider for 340B-covered entities under the 340B Drug Discount Pricing Program. ClearMetrX ClearMetrX, a wholly-owned data management company, offers services that support healthcare organizations across the country. In September 2022, ClearMetrX launched the 340MetrX Platform, a software product developed by ClearMetrX that provides 340B-covered entities with data insights to effectively operate and maximize the benefits of the 340B program. 340MetrX supplies data access and delivers actionable insights that providers and support organizations can use to improve their practices and patient care. Its TPA services include management of wholesale accounts and contract pharmacies, patient eligibility with regard to the 340B drug program, development and review of 340B policies and procedures, and management of receivables. Market Opportunity According to an industry report by global consulting firm Berkeley Research Group, gross sales across the 340B drug program were valued at $116 billion in 2021 and are projected to grow to $280 billion by 2026, achieving a CAGR of more than 19% over the period. The 340B drug pricing program allows eligible healthcare clinics and hospitals (the covered entities) to purchase outpatient drugs at a 20-50 percent discount to treat low-income, uninsured, or underinsured populations. The program’s forecast growth is expected to benefit Progressive care’s business of providing 340B program services to covered entities through the nationwide expansion of ClearMetrX, its third-party administration and data-management business. Management Team Charles M. Fernandez is CEO and Chairman of the Board of Directors of Progressive Care. Mr. Fernandez is also the Executive Chairman and CEO of NextPlat Corp. (NASDAQ: NXPL) and has over 30 years of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. In 2008, he joined Fairholme Capital Management. As president, he co-managed all three Fairholme funds and was commended for bringing in a $2 billion gain for shareholders. Throughout his impressive career in media, pharmaceuticals, healthcare, finance and technology, Mr. Fernandez has participated in more than 100 significant mergers, acquisitions and product development projects. He was the founder, chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK) which was successfully sold to Smartrac, a leading developer, manufacturer and supplier of RFID and Internet of Things (“IoT”) solutions and a unit of Avery Dennison Corporation (NYSE: AVY). Other top management team members include Chief Operating Officer Birute Norkute, Chief Financial Officer Cecile Munnik, and Pamela Roberts, who serves as the company’s Pharmacist in Charge. For more information, visit the company’s website at www.ProgressiveCareus.com. NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD

• The healthcare industry has been termed “the most heavily targeted industry for ransomware attacks,” with serious cases increasing from 43 in 2016 to 91 in 2021
• According to Sophos, cybersecurity attacks in this industry attracted remediation costs of about $1.85 million in 2021, up from $1.27 million in 2020, with the most common disruptions including downtime, cancellations of scheduled care, and ambulance diversions
• SideChannel recognizes this issue, and through its team of vCISOs it offers top-tier cybersecurity programs specific to the healthcare sector, ultimately allowing parties to protect their data and assets while ensuring the smooth running of daily operations
• With the growing cases of data breaches worldwide, SideChannel sees a spike in demand for its products and services, and is taking advantage of the growing cybersecurity market, estimated to hit $266.2 billion by 2027

SideChannel (OTCQB: SDCH), a company on a mission to make cybersecurity simple and accessible, is constantly evolving its products and services in response to the rapidly changing cybersecurity environment. This has seen its service offerings expand into a range of industries, including biotech, manufacturing, legal, defense, fintech and others. In particular, healthcare is a sector currently seeing a spike in cybersecurity attacks, and SideChannel is committed to addressing this issue.

A study published by the Journal of the American Medical Association (“JAMA”) in 2022 noted that between 2016 and 2021, the annual number of ransomware attacks more than doubled, from 43 to 91. The report also noted that 44.4% of the cohort disrupted healthcare delivery, with 8.6% leading to disrupted operations of more than two weeks (https://ibn.fm/wnYrG). According to Sophos, a cybersecurity firm, such attacks attracted a remediation cost of about $1.85 million in 2021, up from $1.27 million in 2020, with healthcare establishments such as Tenet Healthcare, based in Dallas, incurring a loss of about $100 million attributed to a single ransomware attack (https://ibn.fm/Adux4).

The study established that common disruptions associated with ransomware attacks included downtime at 41.7%, cancellations of scheduled care at 10.2%, and ambulance diversions at 4.3%. In addition, day-to-day cyberattacks can lead to breached records, with a recent incident at the Southern Ohio Medical Center resulting in leaked data of more than 15,000 individuals (https://ibn.fm/SPmFj).

The healthcare industry has been termed “the most heavily targeted industry for ransomware attacks,” closely followed by critical manufacturing and government. SideChannel recognizes this issue and looks to remedy the situation, particularly given how integral the healthcare sector is. Through its team of virtual Chief Information Security Officers (“vCISOs”), the company is offering top-tier cybersecurity programs for the healthcare sector, ultimately protecting their data and assets while ensuring the smooth running of day-to-day operations.

“Where we step in is, obviously, identifying and knowing what can slow (the attackers) down, what can stop them, (and) what can be built at an organization that allows you to feel much better about your cybersecurity posture in addressing those risks and addressing regulatory concerns, and addressing the questions from your board or your C-suite- being able to put your customers’ concerns at ease,” noted Brian Haugli, SideChannel’s CEO (https://ibn.fm/Q2IG7).

With the growing cases of data breaches worldwide, SideChannel sees a spike in demand for its products and services. By tailoring them based on the industries it targets, the company is differentiating itself from the other players in the industry. It does so while offering a unique value proposition that sees healthcare organizations, manufacturing firms, and companies within the fintech space procure its products and services. In addition, its approach is helping the company take advantage of the growing cybersecurity market, estimated to hit $266.2 billion by 2027 while also creating value for its shareholders.

For more information, visit the company’s website at www.SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

Leading Investment Research Firm Maintains Buy Rating

Citing strong revenue growth and expectations to ramp through 2025, Chardan Capital Research just issued a new report maintaining its buy rating for Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) and pegs the stock at about 8X current levels. In the report, Chardan states in part, “… Freight Technologies is applying a proven solution to a legacy sector; upside remains compelling from current levels.”

A big part of what makes Freight Technologies so compelling is the transformative nature of its technology that’s modernizing the antiquated systems of an extremely important industry – cross border North American trade under USMCA, which reached nearly $900 Billion in 2022. To address this booming market, Freight Technologies custom-developed an AI and machine learning powered platform that provides a real-time portal for B2B cross-border and domestic shipping throughout North America.

The company’s platform improves efficiencies and experiences for brokers, carriers and shippers by combining everything in one easy to use and effective control center – optimizing logistics and making fleets more efficient while reducing transportation costs. Little wonder that the company’s Fr8app has quickly become the industry’s leading freight-matching platform.

Other compelling upside factors Chardan cited in the report:

• FRGT offers a streamlined process for cross border shipping and additions of shippers and carriers expected to ramp through 2025E.
• BUY rating and $2.00 price target maintained based on 2.4x its 2025E EV/Revenue multiple.
• FRGT reported 2022 revenue of $25.9mn (vs. forecast $25.1mn) and guided 2023 to ~40% annual growth at $36mn.
• More participants offer “network” effect benefits, similar to how ride-sharing developed, as FRGT remains in a key position to the legacy cross border transit model in the Mexico/U.S. market. 
• Expect more color on development of FRGT’s high margin less than truckload (LTL) business. Forecast revenue from that segment could reach $4mn in 2024E and $6mn in 2025E, at nearly twice whole truckload gross margin.
• Continue to forecast that positive operating leverage will lead to EBITDA profitability in 2025E.
• Projections that revenue will reach $91mn by 2025E, implying a 43% 2022E-2025E CAGR.

Freight Technologies is on a mission to revolutionize cross-border shipping and domestic shipping within the United States-Mexico-Canada (USMCA) region. The company’s state-of-the-art platform provides carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the complex process of international over-the-road shipping.

Fr8app is just one in a suite of platforms developed and deployed by Freight Technologies. The company’s Fr8Tech artificial intelligence powered cloud-based platforms are automating the cross-border over-the-road transportation process, reducing human touch points, expediting load booking times and saving users both time and money across multiple touch points.

Freight Technologies’ Fr8Tech suite of solutions that simplify shipping:

• Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers.
• Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives.
• Fr8TMS – A transportation management system designed to help shippers manage their freight and all the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries.
• Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers.
• Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers to increase visibility and control while supporting better business decisions.
• Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee.
• Fr8Now – The company’s nascent LTL offering in Mexico. More information coming soon.

Headquartered in Houston with multiple locations across the U.S. and Mexico, Freight Technologies has established strong relationships in Mexico, one of the largest trading partners of the U.S. Given the size and importance of North American cross-border trade, it’s surprising that the process is crippled by antiquated systems, fragmentation, and rampant inefficiencies. Most of the legacy players – brokers, shippers and carriers – still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Sprinkle in cross-border complexity and confusion dealing with customs, language barriers and additional paperwork, and the result is an industry ripe for technological disruption.

Freight Technologies intends to transform this highly important yet moribund sector by delivering AI powered solutions to complex cross border logistics. Chardan Capital Research has recognized that fact and believes the stock is currently undervalued. Even if the forecast is only half right, there’s big money to be made.

For more information, visit the company’s website at www.Fr8Technologies.com. 

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Outer Edge LA welcomes innovators, enthusiasts, experts, and leaders in technology, entertainment, and Web3, to this year’s event being held in Los Angeles from March 20-23. The event promises to be bigger and better than ever, with a star-studded lineup of award-winning actors, NBA all-stars, startup founders, and blockchain enthusiasts. Outer Edge terms this “an experiential event like no other,” with unique offerings, including co-creation, a unique approach to accessibility, and an experiential approach to learning and interacting with technology and people in the tech space.

This year’s event is founded on five main imperatives – Unite, Build, Give, Experience, and Grow. It offers a platform for people in the tech space to join forces and co-create an out-of-this-world experience while equipping them with the power to shape the event and leave their mark. It also offers an opportunity for attendees to celebrate and acknowledge each individual’s unique gifts and talents, allowing them to live fully in the moment and inspire transformation.

Outer Edge LA will feature workshops, expos, community parties, and even a fashion show, as well as nightlife events. It will also spot a unique showcase for Seed to Series A level startups to compete for startup glory on March 23, building up on the preceding events in the previous week, such as the LA Hackathon.

Last year’s event saw over 3,500 attendees and 150 partnerships with world-class brands. In addition, it featured over 350 NFT brands and reached over 12 million from top media partners. This year’s event seeks to build on that success, bringing in even more sponsors and partners, including Raze, Fio, MINTangible, and RoofStockonChain, and an even bigger crowd of tech enthusiasts.

To learn more, please visit https://ibn.fm/b271k.

• EverGen Infrastructure have expanded its operations to encompass organic waste processing, through its Sea to Sky Soils facility
• Sea to Sky Soils, which is operated in partnership with the Lil’wat First Nation, processes organic material into a wide variety of quality soils, compost and landscape material
• The waste processor recently signed an agreement with a BC district ensuring the supply of over 10,000 tonnes of organic waste feedstock per annum over the next 3 years
• With EverGen playing an increasingly crucial role in furthering Canada’s net zero ambitions, the company’s CEO Chase Edgelow was recently recognized in The Global and Mail’s annual list of 50 Changemakers

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), has long operated at the forefront of Canada’s renewable natural gas (“RNG”) industry. Whilst relatively nascent in nature, the renewable natural gas sector – comprising of processed biogas sourced from landfills, dairy farms and organic waste, has experienced tremendous growth in recent years with production facilities increasingly being rolled out across the U.S. and Canada. In 2021 alone, RNG production capacity in the United States swelled to approximately 660 million gallons gasoline equivalents (“GGE”), a 20 percent increase relative to the prior year. Since commencing operations 12 years ago, EverGen has been an active participant in the sector’s exponential growth trajectory. Boasting 4 revenue generating assets already in operation, the company has recently announced plans to grow its cumulative gross RNG generating capacity to 480,000 gigajoules of energy per annum in the near future, a process which could grow the company’s EBITDA by upwards of 300 percent (https://ibn.fm/p5DyG).

Whilst it has established itself as a mainstay within the RNG field, EverGen Infrastructure have sought to adopt an increasingly holistic view surrounding the renewable energy and waste processing industry. In early 2022, Canada announced its goal to decrease the quantity of waste deposited in its landfills by 30 percent as of 2030 and 50 percent by 2040 (https://ibn.fm/6Dqwr). As part of that overarching ambition, EverGen have founded Sea to Sky Soils, an organic waste processing site operated in partnership with Lil’wat First Nation, seeking to transform and process organic material into high quality soils, compost and landscape materials destined for use by farmers, home gardeners, landscapers and developers.

The business has quickly become one of the largest regional processors of organics within Canada’s British Columbia region, recently announcing that it has signed multiple contracts with a BC regional district for the processing of organic waste at the facility, which provides over 10,000 tonnes per annum (https://ibn.fm/ifTVW). The contract will provide Sea to Sky Soils with increased certainty on the supply of organic feedstock through 2025 with a preferred partner.

“Contracts such as this de-risk our core business and represent another step towards our goal of providing solutions for over 300,000 tonnes of organic waste per annum in the region,” Stated Edgelow.

Through projects such as its Fraser Valley biogas facility, which converts the methane produced by food scraps and manure into RNG and now, its Sea to Sky Soils facility, EverGen Infrastructure has become an integral part of the mission towards achieving Canada’s Net Zero ambitions in the near future. As such, it comes as little surprise that EverGen Infrastructure Co-founder Chase Edgelow was recently recognized as one of 50 Changemakers in The Global and Mail’s annual list. The ambition of the list has been to recognize the activists, executives, entrepreneurs, and academics who have single-mindedly devoted themselves towards making the world a better place. Through its ambition towards transforming the world’s energy consumption and making the earth a cleaner home for all, EverGen Infrastructure certainly made the cut (https://ibn.fm/EPSMh).

For more information, visit the company’s website at www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• Eloro Resources saw its corporate listing upgraded to trade on the TSX exchange as of March 6, 2023
• The uplisting to the TSX main board provides the company with access to greater stock liquidity and increases its visibility amongst larger institutional investors
• The upgrade marks the latest feat for Eloro Resources, with the company having successfully completed a C$10.9mn capital raising in January
• Eloro Resources are aiming to publish their initial resource estimates for their Iska Iska project by the end of 1Q 2023

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently revealed that the company had seen its corporate listing upgraded to trade on the TSX exchange from the TSX-V market as of Monday, March 6th, 2023. The upgrade to the TSX or Toronto Stock Exchange marks a significant milestone for Eloro Resources, enabling the company to access a broad array of new domestic and global investors which may have not previously been able to invest in the stock whilst simultaneously, opening up a new financing avenue for the firm.

The Toronto Stock Exchange (“TSX”) has long distinguished itself as the flagship Canadian stock market; however and typically, access to the market has been limited to well-established corporates boasting a market capitalization of over $50 million. On the other hand, the TSX Venture Exchange (“TSXV”), formerly known as the Canadian Venture Exchange, has dedicated itself towards providing earlier-stage companies with access to public venture capital in an effort to help spur growth and establish a footprint within the Canadian capital market space. Notably, the majority of TSXV companies are valued at between $500,000 and $20 million, whilst enjoying a corporate disclosure burden which is far less stringent than those to which TSX-listed companies are subject to.

Ove the years, the TSX has welcomed over 650 TSX-V listed companies; today, approximately 20% of all companies included within the TSX composite index trace their roots to the TSX-V. To graduate to the primary exchange, TSX-V listed companies must first meet the specific TSX listing requirements related to their particular industry, following which they must submit an application, audited financial statements and recent quarterly statements to be reviewed by the TSX’s board – a lengthy yet rewarding process which Eloro Resources have successfully navigated in recent months.

The upgrade in its stock listing marks the latest feat for Eloro Resources, with the company having announced earlier in January that it had concluded its fully-underwritten primary share placement, raising total gross proceeds of C$10,919,570. At the time the company revealed that the net proceeds derived from the offering would be destined towards exploration and development purposes at the company’s ongoing mining projects in Bolivia as well as for general working capital purposes.

Since commencing its inaugural drill program at the Iska Iska site in September 2020, Eloro Resources have completed a cumulative 84,495 meters of drilling across 122 holes at Iska Iska (https://ibn.fm/hu4O3), with the company anticipating the publication of the initial resource estimates by the end of March 2023. The company have now sought to shift shift their focus towards exploring the feasibility of identifying a second potential world-class tin deposit at Iska Iska, in addition to the already identified, silver-tin polymetallic deposit in Santa Barbara (n.b. a location within the project site).

Following the company’s recent uplisting to the Toronto Stock Exchange main board, successful capital raising exercise and benefitting from exponential demand growth for both, silver and tin as a result of the ongoing global transition towards renewable energy sources, Eloro Resources look well placed to capitalize on any forthcoming resources discoveries in the coming months.

For more information, visit the company’s website at www.EloroResources.com.

NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

• Battery Mineral Resources is focused on the discovery, acquisition and development of battery metal projects in North America, South America and South Korea
• The company’s flagship Punitaqui mine has the potential to generate an annual EBITDA of up to $50 million at or above a copper price of $4.25/lb. with production targeted for H2 of this year
• BMR is working to secure final funding for the restart of mining and resumption of copper concentrate production from its Punitaqui complex; it in advanced discussions with several parties and has the goal of closing a funding agreement in the coming months
• In the second half of 2022, BMI made significant progress toward increasing and improving its human and financial resources, as well as permitting, metallurgy and ESG initiatives
• The company is strategically positioning itself to take advantage of renewed positive market sentiment for near term copper pricing

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) is a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration and acquisitions in favorable mining jurisdictions.

The company’s mission is the discovery, acquisition and development of battery metals (namely copper, cobalt, lithium, and graphite) in North America, South America and South Korea. It aims to become a leading low-cost producer of high quality, ethically sourced battery metals from high-grade, low impact mines in stable jurisdictions that are close to major consumer industries.

BMR is headquartered in Vancouver, British Colombia, with a portfolio of projects spanning Canada, the U.S., Chile and South Korea.

Project Portfolio

BMR’s current focus is the restart of its Punitaqui copper mine in Chile, as well as the exploration and development of its cobalt, lithium and graphite assets in North America and South Korea. The company also continues to identify and evaluate new project opportunities in its operating jurisdictions.

Its current portfolio includes:

Chile – Copper

BMR’s 100%-owned Punitaqui copper mine, acquired in March 2021, has the potential to generate an annual EBITDA of up to $50 million at or above a copper price of $4.25/lb. The company’s flagship project, the Punitaqui mine has been the subject of numerous milestones in recent months, including:

• BMR funded and completed a successful 32,526m resource drill program in 2022. Metallurgical testwork has confirmed the ability to produce excellent copper concentrates from each of the five zones tested, including recoveries ranging from 81% on the low end at Cinabrio Norte up to 96.5% at the Dalmacia deposit.
• The company in August 2022 reported the results of its first ever NI 43-101-compliant resource estimate for the underground deposits at its Punitaqui copper mining complex of 6.2 million tonnes grading 1.14% Cu in indicated category, along with 3.1 million tonnes grading 0.93% Cu in the inferred category. This resource estimate greatly exceeded management goals.
• In September 2022, BMR announced the approval by the Chilean Environment Assessment Service for the Environmental Impact Declaration (“DIA”) pertaining to mining at the company’s Cinabrio mine and San Andres deposit. The approval of the DIA allows BMR to move forward with starting mining operations in 2023 and restarting the mill at its Punitaqui copper mining complex soon after.
• BMR is focused on securing the final funding for the restart of mining and resumption of copper concentrate production at Punitaqui. Once this funding is received, BMR aims to complete mine rehabilitation and development in four to six months, with the ramp up from first production to the full production rate of 20-25 million pounds of copper in concentrate per annum to require a further four to six months.

“From exploration, engineering, community and permitting successes to realizing several non-dilutive means of funding to allow BMR to advance the project, our team looks forward to taking advantage of the renewed positive market sentiment for near term copper pricing and placing ourselves in a strong position to participate in a robust copper sector in 2023,” CEO Martin Kostuik stated in a news release.

Canada – Cobalt/Silver

Between 2016 and April 2018, BMR acquired through claim staking, option, joint venture and direct purchase the largest regional land holding in the historic home of high-grade cobalt-silver veins in Canada known locally as the Cobalt Embayment.

As of February 2023, BMR controlled a land package totaling 9 properties with 4,086 tenements that encompass an area of 84,003.39Ha. The key projects within the land package include McAra, Gowganda, Elk Lake, Fabre and Wilder. From 2017-2022, a total of 412 holes/51,452.34m were drilled on eight projects/20 targets. In addition, a total of 26,709 Line-Km of airborne geophysical surveys & 1,324.84sqkm of LiDAR topography was flown. Follow-up ground geophysical surveys resulted in a total of 37 surveys (514.64 Line-Km) being completed.

Initial NI 43-101 compliant resource defined at McAra (M&I Resource of 1,124,000lbs Co) was detailed in a Technical Report on Cobalt Exploration Assets in Canada dated as of February 5, 2021, with an effective date of October 31, 2020, prepared by SRK Consulting – G Cole PGeo (APGO#1416).

Idaho – Cobalt

BMR holds the Bonanza and East Fork properties located in the historic cobalt-copper-gold Blackbird mining district (Blackbird Mine from 1902-1963 produced 17Mt grading 0.7% Co, 1.4% Cu, and 1 g/t Au) located about 30 kilometers west of Salmon, Idaho. The Bonanza project is immediately adjacent to Jervois Global’s Idaho Cobalt Operations, the United States’ only operating primary cobalt mine. At Bonanza, there are seven mineralized sites within an area over three kilometers wide that extends along a gabbro dyke striking continuously for over six kilometers northward from Noranda’s historic Blackbird Cobalt/Copper mine. The showings on the project are Bonanza Copper Tunnels, Tinker’s Pride, Bonanza Copper #25, Indian Creek, Gray Copper, Blackrock #4 and Papoose #’s 1-4.

From 2018-2021, BMR’s Bonanza Exploration included 550 line-km of airborne magnetics and radiometrics followed up by surface exploration that included rock sampling, soil sampling, channel sampling of historic workings and 3.6km of time domain induced polarization geophysics.

The two properties cover 12 significant cobalt-copper prospects within the known mineralized zone. Both of the BMR Idaho cobalt belt properties host excellent high-grade discovery potential.

South Korea – Graphite

BMR has 100% ownership of the Guemam and Taehwa graphite exploration projects containing high-purity flake graphite deposits. Both assets are past-producing mines with existing local infrastructure and near-term production potential.

Nevada – Lithium

The company’s Amargosa lithium project is in the southern Basin & Range province and central Mojave Desert of Nevada. It is an early-stage exploration opportunity in a favorable region that hosts numerous lithium occurrences, including the Clayton Valley lithium deposit owned by Cypress Development Corp., as well as a major nearby lithium brine mine currently in production called the Silver Peak mine held by Albermarle Corp., one of the world’s largest lithium producers.

Market Opportunity

Near-term forecasts for the copper sector are extremely bullish, with stalwart Wall Street firms such as Goldman Sachs and Bank of America projecting record highs in the coming months. A combination of short-term supply deficits and long-term energy transition demand are expected to buck the downward pressures that have impacted copper prices in recent years.

Goldman in December 2022 forecast a 178K metric ton deficit in the copper market in 2023, causing the firm to raise its 12-month target to $11K/ton and its average price for calendar 2023 to $9,750/ton.

With China likely to continue accelerating efforts to restock depleted inventories in the wake of its COVID-19 reopening and a sustained push toward electrification around the globe placing a strain on supply, BMR is uniquely positioned to capitalize through the anticipated restart of operations at its Punitaqui copper mine.

Management Team

JMartin Kostuik is CEO and a Director of BMR. He brings to the company nearly three decades of diversified experience in the mining industry as a mining engineer and senior executive. Prior to joining BMR, Mr. Kostuik served as president and director of Arizona Gold Corporation and as CEO and director of Rupert Resources Limited. He built a broad base of experience in operations, engineering, exploration and capital projects with various companies including Luna Gold (Equinox), Barrick Gold Corporation, Taseko Mines Limited and DMC Mining Services. Mr. Kostuik earned his B.S. in Mining Engineering from Queen’s University and his M.B.A. from the University of Tennessee.

JMax Satel is the company’s CFO. He has over 18 years of experience as a successful natural resources-focused executive, most recently serving as EVP Corporate Development & Investor Relations for Arrow Exploration Corp., a TSX Venture- and AIM-listed oil & gas company with operations in Colombia and Canada. Prior to joining Arrow, Mr. Satel was principal and co-founder of Bordeaux Capital Inc., a Toronto-based advisory firm focused on the capital needs of companies across the natural resources sector, where he led and executed project financing advisory mandates involving global financial institutions and private equity funds. He earned a Bachelor of Commerce in Finance and Economics from the University of Toronto.

Jacob Willoughby is VP Corporate Development & Strategy for BMR. He brings to the company nearly 17 years of diversified experience in mining capital markets, including over eight years as a mining analyst covering exploration and development companies globally in both precious and base metals. Mr. Willoughby was most recently Vice President of Research and Analyst at Red Cloud Securities in Toronto. He spent two years as President and Director of Aldridge Minerals, a former Canadian based public exploration and development company with assets in Turkey and Papua New Guinea. Mr. Willoughby earned both a B.S. in Geology and a Masters in Business Administration from the University of Windsor.

For more information, visit the company’s website at www.BMRCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to BTRMF are available in the company’s newsroom at https://ibn.fm/BTRMF

Clinical research executives, data management specialists, and industry experts, are all invited to attend the 3rd Risk Based Quality Management Summit that will be held from April 25-26, 2023 at the Le Méridien, in Philadelphia. The summit will be focused on conferring the details of executing data flow process maps, data monitoring tools, audit trails, and quality tolerance limits.

RBQM is now being embraced to address the significant increase in research duration, cost, and complexity of clinical research. The newest version of the Good Clinical Practice (“GCP”) quality standard extends the RBM approach to every facet of study execution, implementing the principles to all parts of quality management needing effective centralized monitoring systems and processes.

The 3rd Annual RBQM Summit will provide real-world lessons from businesses on the leading edge of execution and promote RBQM. This two-day event will feature plenary keynotes from biopharma thought leaders, focused on explicit functions and issues within clin ops, as well as research enterprise and innovation, with interactive and informal breakout discussion groups and networking.

Featured Topics and Discussions:

• Nurture a culture of efficiency and ensure end-to-end quality, cost management, and reliability
• Improve monitoring to include remote data monitoring, site and central monitoring
• Refine skills for risk identification, response, and mitigation
• Ensure the efficiency of QTLs and KRIs
• Ways to respond to central monitoring outputs

A risk-based approach to clinical trials helps to decrease trial costs and complexity while maximizing the R&D budget. The best practices in RBQM influence decentralized trials and clinical study methodology, focusing on risk-based data review including central and site monitoring.

The 3rd Risk Based Quality Management Summit is designed to help you establish cross-functional risk-management teams to manage your clinical trials, decreasing risks and improving drug development. Attendees will get access to valuable information on relevant matters in the risk-based management and monitoring space. Attendees can make the most of this engagement opportunity featuring live sessions, downloadable resources, and Q&A sessions.

Register today and hear the experts share advanced approaches and best practices to optimize data quality and improve risk management and trial efficiency.

To learn more, please visit https://ibn.fm/FYN